The efflux transport of choline through blood-brain barrier is inhibited by Alzheimer's disease therapeutics

2Citations
Citations of this article
7Readers
Mendeley users who have this article in their library.

Abstract

In the present study, we examined the effects of several therapeutics of Alzheimer's disease, such as donepezil hydrochloride, tacrine and α-phenyl-n-tert-butyl nitrone (PBN) on choline efflux from brain to circulating blood. The brain-to-blood efflux of [3H]choline in rats was significantly inhibited by tacrine and PBN. Also the [3H]choline efflux was reduced by tacrine and donepezil hydrochloride in the TR-BBB cells, in vitro the blood-brain barrier (BBB) model. These results suggest that these drugs may influence choline efflux transport from brain to blood and regulate the choline level in brain resulting in the increase of acetylcholine synthesis.

Cite

CITATION STYLE

APA

Lee, N. Y., & Kang, Y. S. (2008). The efflux transport of choline through blood-brain barrier is inhibited by Alzheimer’s disease therapeutics. Biomolecules and Therapeutics, 16(3), 179–183. https://doi.org/10.4062/biomolther.2008.16.3.179

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free